A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation.
about
Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulatorIdentification of a small molecular insulin receptor agonist with potent antidiabetes activity.Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.Novel therapeutics for type 2 diabetes: insulin resistance.
P2860
A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@en
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@nl
type
label
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@en
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@nl
prefLabel
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@en
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@nl
P2860
P356
P1476
A novel hydroxyfuroic acid com ...... o insulin receptor activation.
@en
P2093
Henry J Tsai
Shan-Yen Chou
P2860
P2888
P356
10.1186/1423-0127-16-68
P577
2009-07-30T00:00:00Z
P5875
P6179
1004426971